Total Funding
58
31
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
171015
Vanquish Oncology develops targeted, small-molecule oncology therapeutics for unmet or underserved cancer markets.
Ted Tarasow: Founder & CEOPast Role: HealthTell, Vice President, Product Development
About the Company
Vanquish Oncology is a biotechnology company that develops targeted, small-molecule oncology therapeutics for unmet or underserved cancer markets. It features an advanced program in selectively triggering cancer cell death through activating procaspase 3, a key late-stage effector of apoptosis.
The company was founded in 2011 and headquartered in
Champaign, Illinois.
